Hing C. Wong, Ph.D. 13D and 13G filings for HCW Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 4:30 pm Purchase | 2025-05-15 | 13D | HCW Biologics Inc. HCWB | Hing C. Wong, Ph.D. | 501,911 23.380% | 501,911 (New Position) | Filing |